kynurenine has been researched along with Congestive Ophthalmopathy in 1 studies
Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This work aimed to characterize the kynurenine pathway, activated during interferon-γ (IFN-γ)-mediated inflammation and cellular (T-helper type 1 [Th1] type) immunity, in GD patients with and without thyroid eye disease (TED)." | 8.31 | Systemic Activation of the Kynurenine Pathway in Graves Disease With and Without Ophthalmopathy. ( Breivik, LE; Husebye, E; Løvås, K; Nilsen, RM; Rødahl, E; Stokland, AM; Ueland, GÅ; Ueland, HO; Ulvik, A; Wolff, ASB, 2023) |
| "This work aimed to characterize the kynurenine pathway, activated during interferon-γ (IFN-γ)-mediated inflammation and cellular (T-helper type 1 [Th1] type) immunity, in GD patients with and without thyroid eye disease (TED)." | 4.31 | Systemic Activation of the Kynurenine Pathway in Graves Disease With and Without Ophthalmopathy. ( Breivik, LE; Husebye, E; Løvås, K; Nilsen, RM; Rødahl, E; Stokland, AM; Ueland, GÅ; Ueland, HO; Ulvik, A; Wolff, ASB, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ueland, HO | 1 |
| Ulvik, A | 1 |
| Løvås, K | 1 |
| Wolff, ASB | 1 |
| Breivik, LE | 1 |
| Stokland, AM | 1 |
| Rødahl, E | 1 |
| Nilsen, RM | 1 |
| Husebye, E | 1 |
| Ueland, GÅ | 1 |
1 other study available for kynurenine and Congestive Ophthalmopathy
| Article | Year |
|---|---|
Systemic Activation of the Kynurenine Pathway in Graves Disease With and Without Ophthalmopathy.
Topics: Biomarkers; Graves Disease; Graves Ophthalmopathy; Humans; Inflammation; Interferon-gamma; Kynurenin | 2023 |